newsfilter
← Latest News
CNBC·

Jazz Pharmaceuticals to buy GW Pharmaceuticals in a $7.2 billion deal

Jazz Pharmaceuticals said on Wednesday it would buy GW Pharmaceuticals in a cash-and-stock deal worth $7.2 billion.